Oral News and Research

RSS

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.

22 Sep 2015

$Bisphosphonate drugs linked to greater risk of atypical hip fractures$

Bisphosphonate drugs linked to greater risk of atypical hip fractures

The use of bisphosphonates, a group of drugs used to prevent hip breakages in women with osteoporosis, is associated with an increased risk of atypical fractures in this joint, understood as those that occur in less frequent locations.

22 Sep 2015

UIC to develop and test outreach program to improve children’s oral health in Chicago

The University of Illinois at Chicago will develop and test an outreach program to reduce cavities in Chicago's low-income and minority infants and toddlers under a five-year, $5 million grant from the National Institutes of Health.

22 Sep 2015

$Common Alzheimer's disease drug increases bone density, reduces fracture risks$

Common Alzheimer's disease drug increases bone density, reduces fracture risks

The most common drug used to treat Alzheimer's disease increases bone mass in mice, according to one of the first research articles published in the new open access journal Heliyon. The authors of the study, from Saitama Medical University in Japan, say this means the drug could also be used to treat bone loss diseases like osteoporosis and periodontitis, following further clinical research.

21 Sep 2015

Report: Birth control pills cause significant increase in stroke risk

Birth control pills cause a small but significant increase in the risk of the most common type of stroke, according to a comprehensive report in the journal MedLink Neurology.

21 Sep 2015

Combination of TXA709 and cefdinir demonstrates synergistic antibacterial activity against MRSA

TAXIS Pharmaceuticals, a drug-discovery company focused on developing a new class of antibiotic agents to treat life-threatening, multidrug-resistant bacterial infections, announced the presentation of results demonstrating the synergistic antibacterial activity of its lead clinical candidate, TXA709, when combined with cefdinir, a third-generation cephalosporin antibiotic.

19 Sep 2015

Researchers identify new way to predict effectiveness of chemotherapy in head and neck cancer patients

Manchester researchers have identified a potential new way to predict which patients with head and neck cancer may benefit most from chemotherapy.

18 Sep 2015

Acute Cardiovascular Care 2015 to be held in Vienna from 17 to 19 October

Acute Cardiovascular Care 2015 will highlight innovations and controversies in the field, guaranteeing great stories on topics relevant to the press.

18 Sep 2015

ACCC survey highlights challenges and recent trends in U.S. cancer programs

The Association of Community Cancer Centers (ACCC) recently released results of its sixth annual Trends in Cancer Programs survey, highlighting the challenges and recent trends seen in U.S. cancer programs.

18 Sep 2015

Blue Cross plans to offer dental products in 2016

Blue Cross and Blue Shield of Minnesota today announced plans to offer dental products in 2016, the result of a new agreement with Pennsylvania-based United Concordia Dental.

15 Sep 2015

School meals paired with popular vegetables less likely to wind up in waste bins

A study led by a team of Texas A&M University System researchers found school meals paired with popular vegetables are less likely to wind up in garbage bins.

15 Sep 2015

Better treatment could be on the horizon for Myasthenia Gravis

Myasthenia Gravis (MG) is a debilitating and potentially deadly disease that can afflict anyone, characterized by severe muscle weakness, affecting control of facial expressions, arm and leg movements, chewing, swallowing, coughing and breathing. There is no cure, only treatment.

14 Sep 2015

ULURU signs definitive agreement to sell common stock to European investors

ULURU Inc., a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products, today announced the signing of a definitive agreement to sell an aggregate of 4,079,539 shares of its common stock at a price per share of $0.38 to a group of European investors, which is expected to result in gross proceeds of $1,550,225.

11 Sep 2015

Aspen Dental opens new office in Richmond, Kentucky

A new Aspen Dental is opening in Richmond, Kentucky on Thursday, September 17. Located at 1072 Barnes Mill Road, the conveniently-located practice will provide dental services that range from dentures and preventive care to general dentistry and restoration.

11 Sep 2015

FGF21 compound in breast milk plays key role in neonatal nutrient absorption, intestinal function

A compound found in breast milk, named fibroblast growth factor 21 (FGF21), plays a key role in neonatal nutrient absorption and intestinal function. FGF21 also contributes to improve newborn growth and metabolic profile.

11 Sep 2015

ACR releases two new publications to improve treatment of polymyalgia rheumatica, gout

The American College of Rheumatology (ACR) has released two new publications - recommendations aimed at improving the treatment of patients with polymyalgia rheumatica (PMR), and new classification criteria for gout.

10 Sep 2015

Comprehensive review looks at safety, efficacy of treatment options for premenstrual dysphoric disorder

Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome that causes major disruption in several areas of life for many women. Many treatment options have been proposed, but which are most effective? A comprehensive review of the evidence, including specific treatment guidelines, is presented in the September Journal of Psychiatric Practice, published by Wolters Kluwer.

9 Sep 2015

Latest ENT research to be presented at AAO-HNSF's annual meeting

The latest research on hearing loss, head and neck cancers, sleep apnea and other otolaryngic topics will be presented in Dallas, TX, September 27-30, at the 2015 Annual Meeting & OTO EXPO? of the American Academy of Otolaryngology--Head and Neck Surgery Foundation (AAO-HNSF), the largest annual meeting of ear, nose, throat, head and neck physicians in the world.

9 Sep 2015

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on discovering, developing and commercializing innovative pain treatments, today announced the launch of OXAYDO (oxycodone HCI, USP) tablets -CII in the United States.

9 Sep 2015

Pitt scientists find faster method to identify pathogens

There are plenty of ways in the lab to determine which bug is bugging you when you're sick. The University of Pittsburgh's Xinyu Liu, Sanford Asher, and colleagues may have found a faster method.

9 Sep 2015

Oral News and Research

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Bisphosphonate drugs linked to greater risk of atypical hip fractures

UIC to develop and test outreach program to improve children’s oral health in Chicago

Common Alzheimer's disease drug increases bone density, reduces fracture risks

Report: Birth control pills cause significant increase in stroke risk

Combination of TXA709 and cefdinir demonstrates synergistic antibacterial activity against MRSA

Researchers identify new way to predict effectiveness of chemotherapy in head and neck cancer patients

Acute Cardiovascular Care 2015 to be held in Vienna from 17 to 19 October

ACCC survey highlights challenges and recent trends in U.S. cancer programs

Blue Cross plans to offer dental products in 2016

School meals paired with popular vegetables less likely to wind up in waste bins

Better treatment could be on the horizon for Myasthenia Gravis

ULURU signs definitive agreement to sell common stock to European investors

Aspen Dental opens new office in Richmond, Kentucky

FGF21 compound in breast milk plays key role in neonatal nutrient absorption, intestinal function

ACR releases two new publications to improve treatment of polymyalgia rheumatica, gout

Comprehensive review looks at safety, efficacy of treatment options for premenstrual dysphoric disorder

Latest ENT research to be presented at AAO-HNSF's annual meeting

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Pitt scientists find faster method to identify pathogens

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News